Annual Cash & Cash Equivalents
$94.44 M
+$6.75 M+7.70%
December 31, 2023
Summary
- As of February 7, 2025, MED annual cash & cash equivalents is $94.44 million, with the most recent change of +$6.75 million (+7.70%) on December 31, 2023.
- During the last 3 years, MED annual cash & cash equivalents has fallen by -$69.28 million (-42.32%).
- MED annual cash & cash equivalents is now -42.32% below its all-time high of $163.72 million, reached on December 31, 2020.
Performance
MED Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$115.31 M
+$7.29 M+6.75%
September 30, 2024
Summary
- As of February 7, 2025, MED quarterly cash and cash equivalents is $115.31 million, with the most recent change of +$7.29 million (+6.75%) on September 30, 2024.
- Over the past year, MED quarterly cash and cash equivalents has increased by +$7.29 million (+6.75%).
- MED quarterly cash and cash equivalents is now -44.03% below its all-time high of $206.03 million, reached on March 31, 2021.
Performance
MED Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MED Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.7% | +6.8% |
| 3 y3 years | -42.3% | -25.4% |
| 5 y5 years | +16.1% | +42.0% |
MED Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.3% | +7.7% | -21.8% | +88.8% |
| 5 y | 5-year | -42.3% | +22.7% | -44.0% | +88.8% |
| alltime | all time | -42.3% | >+9999.0% | -44.0% | >+9999.0% |
Medifast Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $115.31 M(+6.7%) |
| Jun 2024 | - | $108.02 M(+10.8%) |
| Mar 2024 | - | $97.47 M(+3.2%) |
| Dec 2023 | $94.44 M(+7.7%) | $94.44 M(-16.2%) |
| Sep 2023 | - | $112.75 M(-23.5%) |
| Jun 2023 | - | $147.41 M(+19.1%) |
| Mar 2023 | - | $123.75 M(+41.1%) |
| Dec 2022 | $87.69 M(-15.8%) | $87.69 M(+25.8%) |
| Sep 2022 | - | $69.71 M(+14.1%) |
| Jun 2022 | - | $61.07 M(-48.2%) |
| Mar 2022 | - | $118.00 M(+13.3%) |
| Dec 2021 | $104.18 M(-36.4%) | $104.18 M(-32.6%) |
| Sep 2021 | - | $154.52 M(-19.5%) |
| Jun 2021 | - | $191.99 M(-6.8%) |
| Mar 2021 | - | $206.03 M(+25.8%) |
| Dec 2020 | $163.72 M(+112.7%) | $163.72 M(+4.6%) |
| Sep 2020 | - | $156.49 M(+19.6%) |
| Jun 2020 | - | $130.83 M(+44.3%) |
| Mar 2020 | - | $90.67 M(+17.8%) |
| Dec 2019 | $76.97 M(-5.4%) | $76.97 M(-5.2%) |
| Sep 2019 | - | $81.20 M(-15.7%) |
| Jun 2019 | - | $96.31 M(-5.4%) |
| Mar 2019 | - | $101.84 M(+25.2%) |
| Dec 2018 | $81.36 M(+8.4%) | $81.36 M(-1.1%) |
| Sep 2018 | - | $82.31 M(+1.5%) |
| Jun 2018 | - | $81.08 M(-6.8%) |
| Mar 2018 | - | $86.96 M(+15.8%) |
| Dec 2017 | $75.08 M(+43.2%) | $75.08 M(+6.4%) |
| Sep 2017 | - | $70.55 M(+11.1%) |
| Jun 2017 | - | $63.53 M(+17.7%) |
| Mar 2017 | - | $53.97 M(+2.9%) |
| Dec 2016 | $52.44 M(+24.7%) | $52.44 M(-8.2%) |
| Sep 2016 | - | $57.12 M(-2.5%) |
| Jun 2016 | - | $58.61 M(+23.9%) |
| Mar 2016 | - | $47.32 M(+12.6%) |
| Dec 2015 | $42.04 M(+71.9%) | $42.04 M(+7.8%) |
| Sep 2015 | - | $38.99 M(+5.0%) |
| Jun 2015 | - | $37.15 M(+11.1%) |
| Mar 2015 | - | $33.42 M(+36.6%) |
| Dec 2014 | $24.46 M(-32.8%) | $24.46 M(-11.5%) |
| Sep 2014 | - | $27.63 M(-13.7%) |
| Jun 2014 | - | $32.02 M(-22.6%) |
| Mar 2014 | - | $41.36 M(+13.7%) |
| Dec 2013 | $36.38 M(-8.9%) | $36.38 M(-24.2%) |
| Sep 2013 | - | $47.98 M(+8.1%) |
| Jun 2013 | - | $44.41 M(-9.8%) |
| Mar 2013 | - | $49.23 M(+23.3%) |
| Dec 2012 | $39.94 M(+180.0%) | $39.94 M(-8.0%) |
| Sep 2012 | - | $43.41 M(+16.9%) |
| Jun 2012 | - | $37.12 M(+16.2%) |
| Mar 2012 | - | $31.93 M(+123.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $14.26 M(-16.9%) | $14.26 M(-22.7%) |
| Sep 2011 | - | $18.45 M(-34.8%) |
| Jun 2011 | - | $28.29 M(-9.3%) |
| Mar 2011 | - | $31.19 M(+81.7%) |
| Dec 2010 | $17.16 M(+61.9%) | $17.16 M(-15.1%) |
| Sep 2010 | - | $20.21 M(-16.6%) |
| Jun 2010 | - | $24.24 M(+16.5%) |
| Mar 2010 | - | $20.81 M(+96.3%) |
| Dec 2009 | $10.60 M(+476.0%) | $10.60 M(-35.1%) |
| Sep 2009 | - | $16.35 M(+47.6%) |
| Jun 2009 | - | $11.07 M(+75.8%) |
| Mar 2009 | - | $6.30 M(+242.0%) |
| Dec 2008 | $1.84 M(-16.1%) | $1.84 M(-12.0%) |
| Sep 2008 | - | $2.09 M(+2.2%) |
| Jun 2008 | - | $2.05 M(+45.4%) |
| Mar 2008 | - | $1.41 M(-35.9%) |
| Dec 2007 | $2.19 M(+102.3%) | $2.19 M(+4.4%) |
| Sep 2007 | - | $2.10 M(-28.1%) |
| Jun 2007 | - | $2.92 M(+57.4%) |
| Mar 2007 | - | $1.86 M(+71.2%) |
| Dec 2006 | $1.08 M(-26.9%) | $1.08 M(-2.6%) |
| Sep 2006 | - | $1.11 M(-55.3%) |
| Jun 2006 | - | $2.49 M(-34.3%) |
| Mar 2006 | - | $3.79 M(+155.6%) |
| Dec 2005 | $1.48 M(+142.5%) | $1.48 M(-43.8%) |
| Sep 2005 | - | $2.64 M(+114.9%) |
| Jun 2005 | - | $1.23 M(+34.2%) |
| Mar 2005 | - | $916.00 K(+49.7%) |
| Dec 2004 | $612.00 K(-75.8%) | $612.00 K(+29.7%) |
| Sep 2004 | - | $472.00 K(+19.2%) |
| Jun 2004 | - | $396.00 K(-74.3%) |
| Mar 2004 | - | $1.54 M(-39.0%) |
| Dec 2003 | $2.52 M(+201.6%) | $2.52 M(-39.4%) |
| Sep 2003 | - | $4.16 M(+107.9%) |
| Jun 2003 | - | $2.00 M(+4.6%) |
| Mar 2003 | - | $1.91 M(+128.7%) |
| Dec 2002 | $837.00 K(+210.0%) | $837.00 K(-23.8%) |
| Sep 2002 | - | $1.10 M(+58.4%) |
| Jun 2002 | - | $694.00 K(-22.2%) |
| Mar 2002 | - | $892.00 K(+230.4%) |
| Dec 2001 | $270.00 K(+164.7%) | $270.00 K(-46.2%) |
| Sep 2001 | - | $502.00 K(-15.2%) |
| Jun 2001 | - | $592.00 K(+42.3%) |
| Mar 2001 | - | $416.00 K(+307.8%) |
| Dec 2000 | $102.00 K(-33.8%) | $102.00 K(-1.2%) |
| Sep 2000 | - | $103.20 K(+53.8%) |
| Jun 2000 | - | $67.10 K(-72.5%) |
| Mar 2000 | - | $244.00 K |
| Dec 1999 | $154.00 K(-69.4%) | - |
| Dec 1998 | $503.00 K(+97.3%) | - |
| Dec 1997 | $255.00 K(-10.8%) | - |
| Dec 1996 | $286.00 K | - |
FAQ
- What is Medifast annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Medifast?
- What is Medifast annual cash & cash equivalents year-on-year change?
- What is Medifast quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Medifast?
- What is Medifast quarterly cash and cash equivalents year-on-year change?
What is Medifast annual cash & cash equivalents?
The current annual cash & cash equivalents of MED is $94.44 M
What is the all time high annual cash & cash equivalents for Medifast?
Medifast all-time high annual cash & cash equivalents is $163.72 M
What is Medifast annual cash & cash equivalents year-on-year change?
Over the past year, MED annual cash & cash equivalents has changed by +$6.75 M (+7.70%)
What is Medifast quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MED is $115.31 M
What is the all time high quarterly cash and cash equivalents for Medifast?
Medifast all-time high quarterly cash and cash equivalents is $206.03 M
What is Medifast quarterly cash and cash equivalents year-on-year change?
Over the past year, MED quarterly cash and cash equivalents has changed by +$7.29 M (+6.75%)